• F J Alados-Arboledas, J F Expósito-Montes, F González-Rivera, C Santiago-Gutiérrez, L Millán-Miralles, and J de la Cruz-Moreno.
• Unidad de Cuidados Intensivos Pediátricos y Neonatales, Complejo Hospitalario de Jaén, España. fjaladosarbol@supercable.es
• Med Intensiva. 2006 Jan 1;30(1):23-5.

AbstractUtility of inhaled nitric oxide in the treatment of acute respiratory distress syndrome (ARDS) with pulmonary hypertension (PHT) is controversial and there are few studies in the literature that evaluate its effects during prolonged administration. We analyze the case of a 45 day old male patient with un-operated Fallot's tetralogy who developed ARDS and PHT with non-cardiac cause, that required prolonged mechanical ventilation (30 days) and administration of inhaled nitric oxide (INO). Before the INO, the oxygenation index was 19, and at a few minutes of its application it decreased to 15. The patient developed a dependence on INO, tolerating its gradual weaning. Administration could be interrupted at 27 days on onset. We did not observe toxic effects during the administration of INO.

18 keywords...

hide…